Explore All Access
Check if your research matches the topics covered in –ë–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –∏ —Ä–∏—Å–∫ —Ñ–∞—Ä–º–∞–∫–æ—Ç–µ—Ä–∞–ø–∏–∏?
- Degree of match
- Common matching concepts
- Additional journal recommendations
–ë–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –∏ —Ä–∏—Å–∫ —Ñ–∞—Ä–º–∞–∫–æ—Ç–µ—Ä–∞–ø–∏–∏ : Impact Factor & More
eISSN: 2619-1164pISSN: 2312-7821
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
–ë–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –∏ —Ä–∏—Å–∫ —Ñ–∞—Ä–º–∞–∫–æ—Ç–µ—Ä–∞–ø–∏–∏ Journal Specifications
| Overview | |
| Publisher | Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» |
| Language | Russian |
| Publication Time | 12 |
| Editorial Review Process | Double anonymous peer review |
| General Details | |
| Language | Russian |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 12 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Copyright Notice |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in –ë–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –∏ —Ä–∏—Å–∫ —Ñ–∞—Ä–º–∞–∫–æ—Ç–µ—Ä–∞–ø–∏–∏ ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in –ë–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –∏ —Ä–∏—Å–∫ —Ñ–∞—Ä–º–∞–∫–æ—Ç–µ—Ä–∞–ø–∏–∏
Does vitamin D supplementation benefit, harm, or have no effects on pregnant women or their babies?
- 9 Oct 2024
- Safety and Risk of Pharmacotherapy
Title not available
- 4 Oct 2024
- Safety and Risk of Pharmacotherapy
Medication Errors Associated with the Use of Levofloxacin: An Analysis of the National Database of Spontaneous Reports
- 3 Oct 2024
- Safety and Risk of Pharmacotherapy
Social Media as a Source of Information for the Detection of Adverse Drug Reactions in Post-Marketing Surveillance: A Review
- 24 Sep 2024
- Safety and Risk of Pharmacotherapy
Neurotropic Effect of Botulinum Toxin and the Potential of Specific Serum Therapy in Botulism (Review)
- 3 Sep 2024
- Safety and Risk of Pharmacotherapy
Off-Label Use of Neovasculgen for II–III Degree Foot Frostbite: A Case Report
- 29 Aug 2024
- Safety and Risk of Pharmacotherapy
Does vitamin D supplementation benefit, harm, or have no effects on pregnant women or their babies?
- 9 Oct 2024
- Safety and Risk of Pharmacotherapy
Title not available
- 4 Oct 2024
- Safety and Risk of Pharmacotherapy
Medication Errors Associated with the Use of Levofloxacin: An Analysis of the National Database of Spontaneous Reports
- 3 Oct 2024
- Safety and Risk of Pharmacotherapy
Social Media as a Source of Information for the Detection of Adverse Drug Reactions in Post-Marketing Surveillance: A Review
- 24 Sep 2024
- Safety and Risk of Pharmacotherapy
Neurotropic Effect of Botulinum Toxin and the Potential of Specific Serum Therapy in Botulism (Review)
- 3 Sep 2024
- Safety and Risk of Pharmacotherapy
Off-Label Use of Neovasculgen for II–III Degree Foot Frostbite: A Case Report
- 29 Aug 2024
- Safety and Risk of Pharmacotherapy
FAQs on –ë–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –∏ —Ä–∏—Å–∫ —Ñ–∞—Ä–º–∞–∫–æ—Ç–µ—Ä–∞–ø–∏–∏
How many articles did –ë–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –∏ —Ä–∏—Å–∫ —Ñ–∞—Ä–º–∞–∫–æ—Ç–µ—Ä–∞–ø–∏–∏ publish last year? 
In 2023, –ë–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –∏ —Ä–∏—Å–∫ —Ñ–∞—Ä–º–∞–∫–æ—Ç–µ—Ä–∞–ø–∏–∏ publsihed 47 articles.
What is the eISSN & pISSN for –ë–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –∏ —Ä–∏—Å–∫ —Ñ–∞—Ä–º–∞–∫–æ—Ç–µ—Ä–∞–ø–∏–∏?
For –ë–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –∏ —Ä–∏—Å–∫ —Ñ–∞—Ä–º–∞–∫–æ—Ç–µ—Ä–∞–ø–∏–∏, eISSN is 2619-1164 and pISSN is 2312-7821.
Who is the publisher of –ë–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –∏ —Ä–∏—Å–∫ —Ñ–∞—Ä–º–∞–∫–æ—Ç–µ—Ä–∞–ø–∏–∏?
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» is the publisher of Безопасность и риск фармакотерапии.
